Preparing for Prevention of Huntington's Disease (PREVENT-HD)

CompletedOBSERVATIONAL
Enrollment

258

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2025

Conditions
Huntington Disease
Interventions
OTHER

Clinical Assessments

A neurological evaluation will be administered to all participants at baseline, 1 year and 2 year follow-up visits. Motor exams and premorbid IQ assessments will be video-recorded for rater reliability assessments conducted randomly throughout the research project.

DIAGNOSTIC_TEST

MRI Scan

At baseline and 2 year follow-up all participants will undergo a 60-minute 3T MRI scanning session which will consist of measures of the volume of brain tissue and cerebral spinal fluid, as well as connections in the brain measuring water pathways and pictures of the brain active and at rest.

DIAGNOSTIC_TEST

Lumber Puncture (LP)

Participants will be asked to complete a LP at both onsite study visits (baseline and 2 year follow-up). Blood collection following the procedure will consist of about 80mL and will be stored at a repository for biomarker analysis.

Trial Locations (1)

53705

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

lead

University of Wisconsin, Madison

OTHER

NCT04818060 - Preparing for Prevention of Huntington's Disease (PREVENT-HD) | Biotech Hunter | Biotech Hunter